PlainRecalls
FDA Drug Moderate Class II Terminated

APAP 325 mg/Phenylephrine HCl, 5mg Tablets Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-135-00

Reported: February 16, 2022 Initiated: January 26, 2022 #D-0529-2022

Product Description

APAP 325 mg/Phenylephrine HCl, 5mg Tablets Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-135-00

Reason for Recall

CGMP Deviations

Details

Units Affected
451,123 tablets
Distribution
Bulk product was distributed to 3 distributors who may have distributed finished product.
Location
Highland, NY

Frequently Asked Questions

What product was recalled?
APAP 325 mg/Phenylephrine HCl, 5mg Tablets Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-135-00. Recalled by ULTRAtab Laboratories, Inc.. Units affected: 451,123 tablets.
Why was this product recalled?
CGMP Deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on February 16, 2022. Severity: Moderate. Recall number: D-0529-2022.